Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study
Authors:
- 16 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 35 (9) , 1004-1011
Abstract
Background: This study aimed to investigate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of patients with pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome (PA-HSOS). Methods: Patients diagnosed with PA-HSOS and treated in Ningbo No.2 Hospital between November 2017 and October 2022 were enlisted in this retrospective cohort study. Results: This cohort comprised a total of 22 patients with PA-HSOS, of which 12 patients received TIPS treatment and 10 patients experienced conservative treatment. The median follow-up duration was 10.5 months. Baseline characteristics existed with no significant difference between the two groups. No operation failures or any TIPS-associated intraoperative complications were observed after TIPS. In the TIPS group, the portal venous pressure was substantially decreased from 25.3 ± 6.3 mmHg to 14.4 ± 3.5 mmHg after TIPS (P = 0.002). Compared with preoperative, the ascites after TIPS were significantly subsided (P = 0.001) and there existed a considerable decrease in Child-Pugh score. At the end of follow-up, 5 patients died, involving 1 in the TIPS group and 4 in the conservative treatment group. The median survival time was 13 (3–28) months in the TIPS group and 6.5 (1–49) months in the conservative treatment group, respectively. The survival analysis demonstrated that the total survival time of TIPS group was longer than that of the conservative treatment group, no statistical significance was observed (P = 0.08). Conclusion: TIPS may be a secure and effective therapeutic strategy for PA-HSOS patients who do not respond to conservative treatment.Keywords
This publication has 32 references indexed in Scilit:
- Chemokine (C‐X‐C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shuntLiver International, 2015
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)Bone Marrow Transplantation, 2015
- Pyrrolizidine Alkaloids: Potential Role in the Etiology of Cancers, Pulmonary Hypertension, Congenital Anomalies, and Liver DiseaseChemical Research in Toxicology, 2014
- How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantationBritish Journal of Haematology, 2014
- Liver cirrhosisThe Lancet, 2014
- Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloidsJournal of Digestive Diseases, 2011
- Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetumJournal of Hepatology, 2011
- Early Use of TIPS in Patients with Cirrhosis and Variceal BleedingNew England Journal of Medicine, 2010
- The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites ClubHepatology, 2003
- Serous Hepatosis: A Pathogenesis of Hepatic Fibrosis in Jamaican ChildrenBMJ, 1953